文献速递认知障碍与痴呆

橙剂暴露与越南战争时期美国退伍军人痴呆诊断的关联

Agent Orange Exposure and Dementia Diagnosis in US Veterans of the Vietnam Era.
PubMed 文献 · JAMA Neurol · 2021-01-01

在中位5.5年随访中,调整人口学与共病后,橙剂暴露者痴呆诊断风险接近未暴露者的两倍(调整HR 1.68,95%CI 1.59-1.77),且平均早1.25年发病。

要点

  • 橙剂暴露退伍军人的痴呆诊断风险接近未暴露者的两倍(aHR 1.68)。
  • 暴露者痴呆诊断平均比未暴露者早1.25年。
  • 关联在调整死亡竞争风险、人口学及共病后仍存在。

核心结论

  • 橙剂暴露与越南战争时期美国退伍军人痴呆诊断风险接近两倍相关,调整死亡竞争风险、人口学及共病后关联仍存在。

研究设计与样本

  • 采用Fine-Gray竞争风险模型比较推定橙剂暴露者与未暴露者的痴呆诊断时间,以年龄为时间尺度,调整人口学及医疗和精神共病。

主要发现

  • 调整后风险比1.68(95%CI 1.59-1.77)。
  • 暴露者痴呆诊断平均年龄67.5(7.0)岁,未暴露者68.8(8.0)岁,平均早1.25年。
  • 基线时帕金森病、糖尿病和淀粉样变性等多数疾病患病率在暴露与未暴露组间相似。

临床怎么用

  • 对越南战争时期有推定橙剂暴露的退伍军人,应关注认知症状并考虑痴呆评估。
  • 痴呆风险增加提示可将橙剂暴露纳入病史采集以辅助风险分层。

局限性

  • 橙剂暴露为电子健康记录中的推定暴露,非个体生物标志物确认。
  • 研究为观察性队列,残余混杂可能影响关联估计。
  • 作者指出需进一步研究橙剂暴露与痴呆关联的潜在机制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Agent Orange is a powerful herbicide that contains dioxin and was used during the Vietnam War. Although prior studies have found that Agent Orange exposure is associated with increased risk of a wide range of conditions, including neurologic disorders (eg, Parkinson disease), metabolic disorders (eg, type 2 diabetes), and systemic amyloidosis, the association between Agent Orange and dementia remains unclear. OBJECTIVE: To examine the association between Agent Orange exposure and incident dementia diagnosis in US veterans of the Vietnam era. DESIGN, SETTING, AND PARTICIPANTS: This cohort study included Veterans Health Administration data from October 1, 2001, and September 30, 2015, with up to 14 years of follow-up. Analyses were performed from July 2018 to October 2020. A 2% random sample of US veterans of the Vietnam era who received inpatient or outpatient Veterans Health Administration care, excluding those with dementia at baseline, those without follow-up visits, and those with unclear Agent Orange exposure status. EXPOSURES: Presumed Agent Orange exposure documented in electronic health record. MAIN OUTCOMES AND MEASURES: Fine-Gray competing risk models were used to compare the time to dementia diagnosis (with age as the time scale) for veterans with vs without presumed Agent Orange exposure (as per medical records), adjusting for demographic variables and medical and psychiatric comorbidities. RESULTS: The total sample was 511 189 individuals; after exclusions, 316 351 were included in analyses. Veterans were mostly male (n = 309 889 [98.0%]) and had a mean (SD) age of 62 (6.6) years; 38 121 (12.1%) had presumed Agent Orange exposure. Prevalence of most conditions, including Parkinson disease, diabetes, and amyloidosis, was similar at baseline among veterans with and without Agent Orange exposure. After adjusting for demographic variables and comorbidities, veterans exposed to Agent Orange were nearly twice as likely as those not exposed to receive a dementia diagnosis over a mean (SD) of 5.5 (3.8) years of follow-up (1918 of 38 121 [5.0%] vs 6886 of 278 230 [2.5%]; adjusted hazard ratio: 1.68 [95% CI, 1.59-1.77]). Veterans with Agent Orange exposure developed dementia at a mean of 1.25 years earlier (at a mean [SD] age of 67.5 [7.0] vs 68.8 [8.0] years). CONCLUSIONS AND RELEVANCE: Veterans with Agent Orange exposure were nearly twice as likely to be diagnosed with dementia, even after adjusting for the competing risk of death, demographic variables, and medical and psychiatric comorbidities. Additional studies are needed to examine potential mechanisms underlying the association between Agent Orange exposure and dementia.

来源:JAMA Neurol,查看原文。版权归原作者所有。

引用

  1. Martinez S, Yaffe K, Li Y, et al. Agent Orange Exposure and Dementia Diagnosis in US Veterans of the Vietnam Era. JAMA Neurol. 2021. PMID: 33492338. doi:10.1001/jamaneurol.2020.5011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。